Recenlty，professor Chen Guoqiang's team published CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma on Nature Communications.

https://www.nature.com/articles/s41467-024-54354-3